NASDAQ: BMRA - Biomerica, Inc.

Yield per half year: -29.12%
Dividend yield: 0.00%
Sector: Healthcare

Share chart Biomerica, Inc.

Extended chart Simple chart
Financial Markets by TradingView

About Biomerica, Inc.

Biomerica, Inc., a biomedical technology company, develops, patents, manufactures, and markets diagnostic and therapeutic products for the detection and/or treatment of medical conditions and diseases worldwide. The company's diagnostic test kits are used to analyze blood, urine, nasal or fecal specimens from patients in the diagnosis of various diseases, food intolerances, and other medical complications; or to measure bacteria, hormones, antibodies, antigens, or other substances which may exist in the human body, stools, or blood in extremely small concentrations.

more details
It primarily sells its products for gastrointestinal diseases, food intolerances, and various esoteric tests at the physicians' offices and over-the-counter drugstores, and hospital/clinical laboratories. The company is also developing InFoods, that uses a simple blood sample to identify patient-specific foods which may alleviate irritable bowel syndrome symptoms; Helicobacter pylori test that indicates if a patient is infected with the H. Pylori bacteria. In addition, it develops products to indicate if a person has been infected by COVID-19. Biomerica, Inc. was incorporated in 1971 and is headquartered in Irvine, California.
Add to compare list
Add to watchlist
Add to portfolio
Add to notification price

IPO date 2005-01-03
ISIN US09061H3075
Industry Health Care Equipment & Supplies
Sector Health Care
Валюта usd
Валюта отчета usd
Сайт https://www.biomerica.com
Цена ао 0.89
Change price per day: -2.95% (0.325)
Change price per week: +13.09% (0.2789)
Change price per month: -2.08% (0.3221)
Change price per 3 month: +0.127% (0.315)
Change price per half year: -29.12% (0.445)
Change price per year: -74.77% (1.25)
Change price per 3 year: -92.33% (4.11)
Change price per 5 year: -89.38% (2.9702)
Change price per 10 year: 0% (0.3154)
Change price per year to date: -19.13% (0.39)
All parameters

Underestimation

Title Value Grade
P/S 1.94 7
P/BV 1.6 8
P/E 0 0
EV/EBITDA -1.19 0
Total: 5.63

Efficiency

Title Value Grade
ROA, % -50.43 0
ROE, % -65.28 0
Total: 0

Dividends

Title Value Grade
Div yield, % 0 0
DSI 0 0
Total: 0

Debt

Title Value Grade
Debt/EBITDA -0.131 10
Total: 9.6

Growth impulse

Title Value Grade
Yield Revenue, % -19.18 0
Yield Ebitda, % 215.42 10
Yield EPS, % 54.44 7
Total: 6.2
More

Institutions Volume Share, %
Granahan Investment Management LLC 1082672 6.44
Wasatch Advisors LP 953264 5.67
Vanguard Group Inc 609365 3.62
Russell Investments Group, Ltd. 201563 1.2
Potomac Capital Management, Inc. 167700 1
Blackrock Inc. 149707 0.89
Geode Capital Management, LLC 120784 0.72
Susquehanna International Group, LLP 75916 0.45
CapTrust Financial Advisors 58668 0.35
Perritt Capital Management, Inc. 42500 0.25



Head Job title Payment Year of birth
Mr. Gary Lu CPA Principal Accounting Officer & CFO 260k 1981 (44 years)
Ms. Lucy Liu Ph.D. Director of Manufacturing & Technical Operations N/A
Mr. Robert W. Carlson Chief Commercial Officer N/A
Mr. Zackary S. Irani CEO & Director 1966 (59 years)
Mr. Allen C. Barbieri Executive Vice-Chairman of the Board & Corporate Secretary 1958 (67 years)

Address: United States, Irvine. CA, 17571 Von Karman Avenue - open in Google maps, open in Yandex maps
Website: https://www.biomerica.com